查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1236867

糖尿病视网膜病变市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

到 2022 年，全球糖尿病视网膜病变市场将达到 76 亿美元。 展望未来，IMARC Group 预测到 2028 年将达到 108 亿美元，显示 2023 年至 2028 年之间的增长率 (CAGR) 为 6.1%。

糖尿病性视网膜病变 (DR) 是指糖尿病引起的视网膜血管损伤。 该疾病分为两种类型：非增殖性 DR 和增殖性或进行性 DR。 它是由于血糖水平波动导致眼内感光组织异常生长引起的。 DR 的症状包括视野中的暗斑或暗线、视力模糊或波动、色觉障碍和视力下降。 可通过荧光素血管造影、光学相干断层扫描等检查确诊，治疗包括眼内註射类固醇、激光治疗、玻璃体切除术等。

世界上糖尿病患病率上升和老龄化人口增加是推动市场增长的主要因素。 此外，糖尿病致盲率上升也推动了市场增长。 公众越来越意识到可用的治疗方法和早期发现 DR 的好处。 结果是广泛采用了技术先进的程序和设备，包括改进的眼科诊断和手术设备。 这些程序和设备能够实现早期检测、有效治疗、更高的准确性和最小的患者不适。 其他因素，如不断上涨的医疗保健成本、实施有利的政府政策以向大众提供先进的医疗保健服务，以及广泛的研发活动，预计将进一步推动市场。

主要市场细分

  • IMARC Group 分析了全球糖尿病视网膜病变市场报告每个子部分的主要趋势，并预测了 2023 年至 2028 年在全球、区域和国家层面的情况。 该报告按类型、治疗类型和最终用户细分市场。

本报告中回答的关键问题

  • 全球糖尿病视网膜病变市场迄今为止进展如何，未来几年将如何发展？
  • 主要的区域市场是什么？
  • COVID-19 对全球糖尿病视网膜病变市场有何影响？
  • 按类型划分的市场细分情况如何？
  • 按治疗类型划分的市场细分情况如何？
  • 最终用户的市场细分情况如何？
  • 行业价值链中有哪些不同阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球糖尿病视网膜病变市场的结构和主要参与者是什么？
  • 您所在行业的竞争力如何？

内容

第一章前言

第二章范围与研究方法

  • 调查目的
  • 利益相关者
  • 数据源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第 3 章执行摘要

第四章介绍

  • 概览
  • 主要行业趋势

第 5 章糖尿病视网膜病变的全球市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按类型划分的市场细分

  • 增生性糖尿病视网膜病变
    • 市场趋势
    • 市场预测
  • 非增殖性视网膜病变
    • 关于市场趋势
    • 市场预测

第 7 章按治疗类型划分的市场细分

  • 抗 VEGF 药物
    • 关于市场趋势
    • 市场预测
  • 类固醇植入物
    • 关于市场趋势
    • 市场预测
  • 激光手术
    • 关于市场趋势
    • 市场预测
  • 玻璃体手术
    • 关于市场趋势
    • 市场预测

第 8 章最终用户市场细分

  • 用于医院和药房
    • 市场趋势
    • 市场预测
  • 眼科诊所
    • 市场趋势
    • 市场预测
  • 门诊手术中心 (ASC)
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 9 章按区域划分的市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 关于市场趋势
      • 市场预测
    • 日本
      • 关于市场趋势
      • 市场预测
    • 印度
      • 关于市场趋势
      • 市场预测
    • 韩国
      • 关于市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印度尼西亚
      • 市场趋势
      • 市场预测
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 关于市场趋势
      • 市场预测
    • 西班牙
      • 关于市场趋势
      • 市场预测
    • 俄罗斯
      • 关于市场趋势
      • 市场预测
    • 其他
      • 关于市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 关于市场趋势
      • 市场预测
    • 墨西哥
      • 关于市场趋势
      • 市场预测
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场预测

第 10 章 SWOT 分析

  • 概览
  • 力量
  • 弱点
  • 机会
  • 威胁

第11章价值链分析

第12章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Alimera Sciences
    • Allergan Plc
    • Ampio Pharmaceuticals
    • Bayer Healthcare
    • BCN Peptides
    • Genentech
    • Kowa Group
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Sirnaomics Inc.
Product Code: SR1523A132_Report

The global diabetic retinopathy market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of two kinds, namely non-proliferative DR and proliferative or advanced DR. It is caused by fluctuations in the blood glucose levels resulting in an abnormal growth in the light-sensitive tissues present in the eye. The symptoms of DR include the visibility of dark spots or floating strings in the vision field, blurred or fluctuating vision, impaired color vision or loss of vision. It can be diagnosed through tests, such as fluorescein angiography and optical coherence tomography, and the treatment involves the use of intraocular steroid injection, laser treatment and vitrectomy.

The increasing prevalence of diabetes, along with the growing geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the rising incidence of blindness caused by DR is also providing a boost to the market growth. There is an increasing awareness among the masses regarding the available treatment alternatives and the benefits of early detection of DR. This has resulted in the widespread adoption of technologically advanced procedures and equipment, such as the improved ophthalmic diagnostic and surgical instruments. These procedures and equipment enable early detection and efficient treatment of the ailment with higher precision and minimal discomfort to the patient. Other factors, including the increasing healthcare expenditures, the implementation of favorable government policies to make advanced healthcare services available to the masses and extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global diabetic retinopathy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end-user.

Breakup by Type:

  • Proliferative Diabetic Retinopathy
  • Non-proliferative Retinopathy

Breakup by Treatment Type:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

Breakup by End-User:

  • Hospitals and Pharmacies
  • Eye Clinics
  • Ambulatory Surgical Centres (ASCs)
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global diabetic retinopathy market?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global diabetic retinopathy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proliferative Diabetic Retinopathy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proliferative Retinopathy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Anti VEGF Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Steroid Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitrectomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eye Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centres (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Alimera Sciences
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Allergan Plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Ampio Pharmaceuticals
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bayer Healthcare
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 BCN Peptides
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Genentech
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Kowa Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Regeneron Pharmaceuticals Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sirnaomics Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2022
  • Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2022
  • Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2022
  • Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
  • Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
  • Figure 78: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
  • Table 7: Global: Diabetic Retinopathy Market: Key Players